These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 2969281)

  • 1. Development and characterization of a rat model for locally recurring mammary tumors: sensitivities to 5-fluoro-2'-deoxyuridine, adriamycin, and X-irradiation.
    Welch DR; Aeed PA; Estrada J
    Cancer Res; 1988 Aug; 48(16):4549-54. PubMed ID: 2969281
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Experimental model for locally recurring mammary tumors. Development, morphology, karyotype, growth kinetics, and experimental metastatic potential.
    Estrada J; Freeman DL; Aeed PA; Welch DR
    Cancer; 1989 Apr; 63(7):1353-62. PubMed ID: 2920363
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Growth of rat mammary adenocarcinoma cells in semisolid clonogenic medium not correlated with spontaneous metastatic behavior: heterogeneity in the metastatic, antigenic, enzymatic, and drug sensitivity properties of cells from different sized colonies.
    Nicolson GL; Lembo TM; Welch DR
    Cancer Res; 1988 Jan; 48(2):399-404. PubMed ID: 2825974
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phenotypic drift and heterogeneity in response of metastatic mammary adenocarcinoma cell clones to adriamycin, 5-fluoro-2'-deoxyuridine and methotrexate treatment in vitro.
    Welch DR; Nicolson GL
    Clin Exp Metastasis; 1983; 1(4):317-25. PubMed ID: 6242707
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heterogeneity in the sensitivities of the 13762NF rat mammary adenocarcinoma cell clones to cytolysis mediated by extra- and intratumoral macrophages.
    North SM; Nicolson GL
    Cancer Res; 1985 Apr; 45(4):1453-8. PubMed ID: 3978611
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development and biologic properties of malignant cell sublines and clones of a spontaneously metastasizing rat mammary adenocarcinoma.
    Neri A; Welch D; Kawaguchi T; Nicolson GL
    J Natl Cancer Inst; 1982 Mar; 68(3):507-17. PubMed ID: 6950180
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monoclonal antibodies against cell-surface antigens of the metastatic rat 13762NF mammary adenocarcinoma and their cross-reactivity with human breast carcinomas.
    North SM; Steck PA; Nicolson GL
    Cancer Res; 1986 Dec; 46(12 Pt 1):6393-9. PubMed ID: 3779654
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Progression and enhancement of metastatic potential after exposure of tumor cells to chemotherapeutic agents.
    De Larco JE; Wuertz BR; Manivel JC; Furcht LT
    Cancer Res; 2001 Apr; 61(7):2857-61. PubMed ID: 11306458
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Experimental characterization of recurrent ovarian immature teratoma cells after optimal surgery.
    Tanaka T; Toujima S; Utsunomiya T; Yukawa K; Umesaki N
    Oncol Rep; 2008 Jul; 20(1):13-23. PubMed ID: 18575713
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multiple phenotypic divergence of mammary adenocarcinoma cell clones. II. Sensitivity to radiation, hyperthermia and FUdR.
    Welch DR; Evans DP; Tomasovic SP; Milas L; Nicolson GL
    Clin Exp Metastasis; 1984; 2(4):357-71. PubMed ID: 6242285
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor progression- and metastasis-associated proteins identified using a model of locally recurrent rat mammary adenocarcinomas.
    Welch DR; McClure SA; Aeed PA; Bahner MJ; Adams LD
    Clin Exp Metastasis; 1990; 8(6):533-51. PubMed ID: 2225568
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An antiangiogenic urokinase-derived peptide combined with tamoxifen decreases tumor growth and metastasis in a syngeneic model of breast cancer.
    Guo Y; Mazar AP; Lebrun JJ; Rabbani SA
    Cancer Res; 2002 Aug; 62(16):4678-84. PubMed ID: 12183425
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preferential growth stimulation of metastatic rat mammary adenocarcinoma cells by organ-derived syngeneic fibroblasts in vitro.
    Okumura Y; Hamada J; Cavanaugh PG; Nicolson GL
    Invasion Metastasis; 1992; 12(5-6):275-83. PubMed ID: 1298739
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of 'spontaneous' and 'experimental' metastasis using rat 13762 mammary adenocarcinoma metastatic cell clones.
    Welch DR; Neri A; Nicolson GL
    Invasion Metastasis; 1983; 3(2):65-80. PubMed ID: 6677622
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Organization of cytoskeletal structures in 13762NF rat mammary adenocarcinoma cell lines and clones of different metastatic potentials.
    Lichtner RB; Nicolson GL
    Invasion Metastasis; 1987; 7(2):73-82. PubMed ID: 3583622
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.
    Valentini V; Morganti AG; Gambacorta MA; Mohiuddin M; Doglietto GB; Coco C; De Paoli A; Rossi C; Di Russo A; Valvo F; Bolzicco G; Dalla Palma M;
    Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1129-39. PubMed ID: 16414206
    [TBL] [Abstract][Full Text] [Related]  

  • 17. On the development of models in mice of advanced visceral metastatic disease for anti-cancer drug testing.
    Man S; Munoz R; Kerbel RS
    Cancer Metastasis Rev; 2007 Dec; 26(3-4):737-47. PubMed ID: 17846863
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 123I-ITdU-mediated nanoirradiation of DNA efficiently induces cell kill in HL60 leukemia cells and in doxorubicin-, beta-, or gamma-radiation-resistant cell lines.
    Reske SN; Deisenhofer S; Glatting G; Zlatopolskiy BD; Morgenroth A; Vogg AT; Buck AK; Friesen C
    J Nucl Med; 2007 Jun; 48(6):1000-7. PubMed ID: 17504875
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bioluminescent human breast cancer cell lines that permit rapid and sensitive in vivo detection of mammary tumors and multiple metastases in immune deficient mice.
    Jenkins DE; Hornig YS; Oei Y; Dusich J; Purchio T
    Breast Cancer Res; 2005; 7(4):R444-54. PubMed ID: 15987449
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Restoration of tumor oxygenation after cytotoxic therapy by a perflubron emulsion/carbogen breathing.
    Teicher BA; Holden SA; Ara G; Dupuis NP; Goff D
    Cancer J Sci Am; 1995; 1(1):43-8. PubMed ID: 9166453
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.